OralKleen, Inc. — SEC Form D Filing
OralKleen, Inc. filed an SEC Form D on September 17, 2026, reporting $300K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 17, 2026
- Amount reported
- $300K
- Round stage
- Seed
- Industry
- Medical Devices
- Website
- https://oralkleen.com/
What the company does
Securities: Equity, SAFE (Simple Agreement for Future Equity) and shares of capital stock to be issued on conversion of SAFE.. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Intubated patients and those dependent on others for oral care often experience significantly worse oral health outcomes and are at high risk of developing ventilator-associated pneumonia (VAP), which has a high mortality rate. Standard oral care methods are often inadequate in preventing these issues.
Solution
OralKleen provides a comprehensive oral care system including specialized toothpaste, mouth gel, lip balm, and an electric toothbrush with integrated suction and lighting, along with other tools like a scraper and swab stick. This system is designed to improve oral health, reduce VAP rates, and streamline oral care for patients at risk for healthcare-associated pneumonia.
Why now
There is a growing awareness of the critical link between oral hygiene and overall patient health, particularly in preventing healthcare-associated infections like VAP. Advances in medical technology allow for more effective and efficient oral care solutions in clinical settings.
Verdict
This cleared because it offered a tangible solution to a high-cost clinical problem, ventilator-associated pneumonia (VAP), rather than solely relying on general "preventative health" trends. Investors were implicitly betting that a device-plus-consumables model could penetrate established hospital procurement channels and dislodge entrenched, albeit less effective, standard care practices. This narrative limited upside by focusing heavily on VAP, potentially narrowing initial market perception and making broader oral care applications secondary in the investment thesis.
Source: SEC EDGAR Form D filing